A Study Of Smart Horizons For Gastrointestinal Health

Overview

About this study

The purpose of this study is to develop and pilot test the Smart Symptom Tracking ALEX tool using an experimental two-arm design (ALEX vs. standard of care).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Ages 18–44 years
Has an active health insurance plan
Concerned about their GI health
Able to speak and read English
Willing to complete a four-week symptom tracking protocol

Exclusion Criteria:

Unable to understand the informed consent or comply with protocol requirements
Not insured under a health insurance plan

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 03/30/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Jacksonville, Fla. Mayo Clinic principal investigator Janice Krieger, Ph.D.	Contact us for the latest status	Contact information: Alicia Kissinger-Knox (904) 953-5375 kissinger-knox.alicia@mayo.edu

Mayo Clinic Location

Status

Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Janice Krieger, Ph.D.

Contact us for the latest status

Contact information:

Alicia Kissinger-Knox

(904) 953-5375

kissinger-knox.alicia@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials